Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The return on invested capital (ROIC) is N/A as of Tuesday, October 6, 2026.
RETURN ON INVESTED CAPITAL (ROIC)
N/A
MiniMed Group, Inc.
Market Cap
$560.00M
Return on Invested Capital (ROIC)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$557.32M
Return on Invested Capital (ROIC)
-25.42%
TTM Avg
25.46%
3Y Avg
-12.61%
5Y Avg
-20.42%
Market Cap
$571.13M
Return on Invested Capital (ROIC)
27.87%
TTM Avg
-1.63%
3Y Avg
-31.88%
5Y Avg
-39.02%
Market Cap
$548.51M
Return on Invested Capital (ROIC)
-23.45%
TTM Avg
-110.35%
3Y Avg
-97.44%
5Y Avg
-86.64%
Market Cap
$578.40M
Return on Invested Capital (ROIC)
-45.62%
TTM Avg
-46.61%
3Y Avg
-61.97%
5Y Avg
-71.18%
Market Cap
$538.01M
Return on Invested Capital (ROIC)
-78.31%
TTM Avg
-49.75%
3Y Avg
-41.99%
5Y Avg
-101.04%
Market Cap
$583.31M
Return on Invested Capital (ROIC)
-4.97%
TTM Avg
-6.49%
3Y Avg
-6.53%
5Y Avg
-6.86%
Market Cap
$584.48M
Return on Invested Capital (ROIC)
-11.80%
TTM Avg
-7.26%
3Y Avg
-5.22%
5Y Avg
9.70%
Market Cap
$533.04M
Return on Invested Capital (ROIC)
-16.89%
TTM Avg
-20.74%
3Y Avg
-75.97%
5Y Avg
-65.59%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MiniMed Group, Inc. (MMEDV) | $560.00M | N/A | N/A | N/A | N/A |
| CytomX Therapeutics, Inc. (CTMX)vs › | $557.32M | -25.42% | 25.46% | -12.61% | -20.42% |
| CorMedix Inc. (CRMD)vs › | $571.13M | 27.87% | -1.63% | -31.88% | -39.02% |
| Phathom Pharmaceuticals, Inc. (PHAT)vs › | $548.51M | -23.45% | -110.35% | -97.44% | -86.64% |
| Aquestive Therapeutics, Inc. (AQST)vs › | $578.40M | -45.62% | -46.61% | -61.97% | -71.18% |
| ProKidney Corp. (PROK)vs › | $538.01M | -78.31% | -49.75% | -41.99% | -101.04% |
| OrthoPediatrics Corp. (KIDS)vs › | $583.31M | -4.97% | -6.49% | -6.53% | -6.86% |
| Fulgent Genetics, Inc. (FLGT)vs › | $584.48M | -11.80% | -7.26% | -5.22% | 9.70% |
| Monopar Therapeutics Inc. (MNPR)vs › | $533.04M | -16.89% | -20.74% | -75.97% | -65.59% |
| Delcath Systems, Inc. (DCTH)vs › | $531.98M | -0.81% | -8.59% | -110.96% | -102.03% |
ROIC
N/A
ROE
N/A
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
